Metabolomics: A Global Biochemical Approach to the Study of Central Nervous System Diseases

被引：224

作者：

Kaddurah-Daouk, Rima ^{[1
]}

Krishnan, K. Ranga Rama ^{[1
]}

机构：

[1] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA

来源：

NEUROPSYCHOPHARMACOLOGY | 2009年 / 34卷 / 01期

基金：

美国国家卫生研究院;

关键词：

metabolomics; pharmacometabolomics; metabonomics; biomarkers; neurodegenerative; psychiatric diseases; NEURONAL CEROID-LIPOFUSCINOSES; GAMMA-AMINOBUTYRIC-ACID; CEREBROSPINAL-FLUID; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; TYPE-4; ALLELE; GENE; METABONOMICS; BIOMARKERS;

D O I：

10.1038/npp.2008.174

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Metabolomics, the omics science of biochemistry, is a global approach to understanding regulation of metabolic pathways and metabolic networks of a biological system. Metabolomics complements data derived from genomics, transcriptomics, and proteomics to assist in providing a systems approach to the study of human health and disease. In this review we focus on applications of metabolomics for the study of diseases of the nervous system. We share concepts in metabolomics, tools used in metabolic profiling and early findings from the study of neuropsychiatric diseases, and drugs used to treat these diseases. Metabolomics emerges as another powerful tool in central nervous system research.

引用

收藏

页码：173 / 186

页数：14

相关论文

共 101 条

[71] Medical progress: Amyotrophic lateral sclerosis. [J].

Rowland, LP ;

Shneider, NA .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (22) :1688-1700

[72] Metabolomic analysis and signatures in motor neuron disease [J].

Rozen, Steve ;

Cudkowicz, Merit E. ;

Bogdanov, Mikhail ;

Matson, Wayne R. ;

Kristal, Bruce S. ;

Beecher, Chris ;

Harrison, Scott ;

Vouros, Paul ;

Flarakos, Jimmy ;

Vigneau-Callahan, Karen ;

Matson, Theodore D. ;

Newhall, Kristyn M. ;

Beal, M. Flint ;

Brown, Robert H., Jr. ;

Kaddurah-Daouk, Rima .

METABOLOMICS, 2005, 1 (02) :101-108

[73] Metabolomic identification of novel biomarkers of myocardial ischemia [J].

Sabatine, MS ;

Liu, E ;

Morrow, DA ;

Heller, E ;

McCarroll, R ;

Wiegand, R ;

Berriz, GF ;

Roth, FP ;

Gerszten, RE .

CIRCULATION, 2005, 112 (25) :3868-3875

[74] Machine learning for detection and diagnosis of disease [J].

Sajda, Paul .

ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, 2006, 8 :537-565

[75]

Sanacora Gerard, 2007, CNS & Neurological Disorders-Drug Targets, V6, P127, DOI 10.2174/187152707780363294

[76] BIOGENIC-AMINES AND AFFECTIVE-DISORDERS [J].

SCHILDKRAUT, JJ .

ANNUAL REVIEW OF MEDICINE, 1974, 25 :333-348

[77] Serotonin transporter gene variants and behavior: A comprehensive review [J].

Serretti, Alessandro ;

Calati, Raffaella ;

Mandelli, Laura ;

De Ronchi, Diana .

CURRENT DRUG TARGETS, 2006, 7 (12) :1659-1669

[78] A machine learning perspective on the development of clinical decision support systems utilizing mass spectra of blood samples [J].

Shin, HJ ;

Markey, MK .

JOURNAL OF BIOMEDICAL INFORMATICS, 2006, 39 (02) :227-248

[79] From membrane phospholipid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia? [J].

Skosnik, PD ;

Yao, JK .

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2003, 69 (06) :367-384

[80] Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies [J].

Sobczak, S ;

Honig, A ;

van Duinen, MA ;

Riedel, WJ .

BIPOLAR DISORDERS, 2002, 4 (06) :347-356

← 2 3 4 5 6 7 8 9 10 11 →